Medical device company InMode’s latest webinar series ‘Elevate Your Practice with Envision’ held in May 2024 is now available on demand.
Envision is described as a non-surgical, non-drug alternative for dry eye disease (DED) and meibomian gland dysfunction (MGD). Comprising distinct complimentary technologies, Envision adopts both radio frequency technology (Forma-I) and intense pulsed light (Lumecca-I) to treat early and secondary stage of DED.
During the webinar, Canadian optometrist Dr Bruce Dornn – an early adopter of Envision – highlighted practice management strategies including how to be comfortable consulting with clients, how to get them to invest in the treatments, and how to generate revenue. He also explored untapped treatment opportunities in the practice, as well as how to research the best technology solution.
The latest webinar with Dr Dornn can be viewed here:
Find out more about Envision:
More reading
InMode’s live webinar: Elevate Your Practice with Envision
Queensland clinic first to introduce InMode’s dry eye treatment
InMode brings new dry eye care approach to Australia
